Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Min Steve T.
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Valeant Pharmaceuticals International
Valeant Pharmaceuticals International
EVP, General Counsel
Avg. Two Year Performance
196%
Avg. Purchase Return
72%
Compound
No Sale Track Record
Holdings: 0 shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Drug Manufacturers - Other
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
